Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats
Jae Chul Lee, Choong Ik Cha, Dong-Sik Kim, Soo Young Choe
J Pathol Transl Med. 2015;49(6):472-480.   Published online 2015 Oct 16     DOI: https://doi.org/10.4132/jptm.2015.09.11
Citations to this article as recorded by Crossref logo
Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling
Gesheng Cheng, Xingye Wang, Yongxin Li, Lu He
Stem Cell Research & Therapy.2017;[Epub]     CrossRef
Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment
Jae Chul Lee, Kwan Chang Kim, Soo Young Choe, Young Mi Hong
Anatomy & Cell Biology.2016; 49(1): 7.     CrossRef
Right sided heart failure and pulmonary hypertension: New insights into disease mechanisms and treatment modalities
Diana Drogalis-Kim, John Jefferies, Ivan Wilmot, Juan Alejos
Progress in Pediatric Cardiology.2016; 43: 71.     CrossRef
Notice of Retraction: Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats
Jae Chul Lee, Choong Ik Cha, Dong-Sik Kim, Soo Young Choe
Journal of Pathology and Translational Medicine.2016; 50(4): 325.     CrossRef